THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kelly Standifer to Male

This is a "connection" page, showing publications Kelly Standifer has written about Male.
Connection Strength

0.259
  1. Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder. Cell Mol Neurobiol. 2021 Jul; 41(5):1009-1018.
    View in: PubMed
    Score: 0.060
  2. Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions. Behav Brain Res. 2018 03 15; 340:183-194.
    View in: PubMed
    Score: 0.045
  3. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol. 2015 Jan; 172(2):571-82.
    View in: PubMed
    Score: 0.039
  4. Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD. Mol Pain. 2012 Oct 20; 8:76.
    View in: PubMed
    Score: 0.034
  5. Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment. Neuropharmacology. 2012 Sep; 63(3):427-33.
    View in: PubMed
    Score: 0.033
  6. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol Pharmacol. 1996 Aug; 50(2):293-8.
    View in: PubMed
    Score: 0.011
  7. Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression. J Neurochem. 1995 Nov; 65(5):1981-7.
    View in: PubMed
    Score: 0.011
  8. Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb; 339(1-2):129-37.
    View in: PubMed
    Score: 0.007
  9. Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats. Brain Res. 2000 Sep 08; 876(1-2):62-75.
    View in: PubMed
    Score: 0.004
  10. Characterizing kappa3 opioid receptors with a selective monoclonal antibody. Synapse. 1996 Mar; 22(3):247-52.
    View in: PubMed
    Score: 0.003
  11. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett. 1995 Sep 29; 198(2):99-102.
    View in: PubMed
    Score: 0.003
  12. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Mol Pharmacol. 1995 Jun; 47(6):1180-8.
    View in: PubMed
    Score: 0.003
  13. Gender effects and central opioid analgesia. Pain. 1991 Apr; 45(1):87-94.
    View in: PubMed
    Score: 0.002
  14. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 1990 Dec 03; 535(1):101-9.
    View in: PubMed
    Score: 0.002
  15. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989 Nov; 251(2):477-83.
    View in: PubMed
    Score: 0.002
  16. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine. J Neurochem. 1988 Apr; 50(4):1044-52.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES